CLOs on the Move

Oola Life

www.oolalife.com

 
Founded in 2012 by international bestselling authors, work-life balance experts, and holistic healthcare providers, Dr. Dave Braun and Dr. Troy Amdahl, Oola provides a simple and easy-to-follow lifestyle framework designed to lead you, step by step, to a life of less stress, more personal growth, and a clearer path toward living your unique purpose. The concept originally ideated in 1997 as Dr. Braun and Dr. Amdahl worked to better themselves in the seven key areas of life -- Fitness, Finance, Family, Field (career), Faith, Friends, and Fun. Since then, the Oola lifestyle has become a global phenomenon, with over a ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Oxford Health Plans

Oxford Health Plans, Inc. is a healthcare company providing health benefit plans primarily in New York, New Jersey and Connecticut. Its product line includes its health maintenance organization plans, exclusive provider organization plans,

Clinica Medical Research

Clinica Medical Research is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

QueensCare Family Clinics

QueensCare Family Clinics is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. QueensCare Family Clinics is based in Los Angeles, CA. You can find more information on QueensCare Family Clinics at www.queenscare.org

OnPoint Medical Diagnosis

OnPoint Medical Diagnosis is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Minneapolis, MN. To find more information about OnPoint Medical Diagnosis, please visit www.onpointmd.com

Imagin Medical

Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer. Imagin`s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.